Although FDA strives to have broad representation of appropriate medical and scientific specialties on its advisory committees, optimal representation is often difficult to achieve given the strict conflict-of-interest regulations that apply, as well as calendar conflicts, which may limit the availability of experts for the selected meeting dates.
The fact that we now have fixed-term parliaments with general election dates specified years in advance does make it simpler to limit how much can be spent by the parties.